49 results
8-K
EX-1.1
ACXP
Acurx Pharmaceuticals, Inc.
15 Nov 23
Entry into a Material Definitive Agreement
5:02pm
to the Commission’s satisfaction with all requests of the Commission for additional or supplemental information related to the Registration Statement … satisfaction (or waiver by the Sales Agent in its sole discretion) of the following additional conditions:
(a) Registration Statement Effective
8-K
EX-5.1
tfwmwc4o3kj6 gsdld
15 Nov 23
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-4.3
zlnr1 cpy5lbrxrr
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
8-K
EX-4.2
s3b6c1y37hgb bvc
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
8-K
EX-99.1
3n9oquz a9n9
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
8-K
EX-5.1
zpoag
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
8-K
EX-10.2
hgr1gajlqledtjy2x0xu
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
8-K
EX-10.1
j43ey 368tndl5fl88kq
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
8-K
EX-4.1
trkmnjre 50u3h1
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
8-K
EX-10.1
9b5n5szuo1c
25 Jul 22
Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering
8:46am